1. BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE. (17th June 2021) Authors: Ionova, T.; Andrievskikh, M.; Amdiev, A.; Baryakh, E.; Chang, V.; Endakova, A.; Fadeeva, N.; Husainova, G.; Ivanov, V.; Kaplanov, K.; Kaverina, O.; Kiseleva, M.; Klitochenko, T.; Kurakin, V.; Larionova, O.; Lazareva, D.; Lepik, K.; Lysenko, I.; Melnichenko, V.; Mikhailova, N. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗